An assessment of prevalence of Type 1 CFI rare variants in European AMD, and why lack of broader genetic data hinders development of new treatments and healthcare access
SCOPE Study group
- Gyroscope Therapeutics Limited
- Finnish Biobank Cooperative–FINBB
- University of Turku
- Finnish Clinical Biobank Tampere
- University of Helsinki
- University Hospital of Kuopio
- Hospital Nova of Central Finland
- University of Oulu
- Edward S. Harkness Eye Institute
- Tufts University
- Salisbury NHS Foundation Trust
- Strategic Clinical Research Group LLC
- Centre Hospitalier Universitaire de Dijon
- Retina Foundation of the Southwest
- Centre Paradis Monticelli
- Retina Vitreous Associates
- Long Island Vitreoretinal Consultants
- VISSUM Mirasierra
- Oregon Health & Science University
- West Virginia University
- NHS Greater Glasgow and Clyde
- University of Melbourne
- Retina Association of Western New York
- Ophthalamic Consultants of Boston (OCB)
- Mid-Atlantic Retina
- Radboud University Nijmegen
- Department of Cardiovascular Medicine
- Manchester University NHS Foundation Trust
- Oftalmika—Prywatna Klinika Okulistyczna
- Sierra Eye Associates
- Centre Hospitalier Universitaire de Poitiers
- Midwest Eye Institute
- Leeds Teaching Hospitals NHS Trust
- Wolfe Eye Clinic
- Retina Center Northwest
- University Hospital Hamburg-Eppendorf
- City Hospitals Sunderland NHS Foundation Trust
- Retina Care Center
- Columbia University Medical Center
- New Jersey Retina Research Foundation
- Spokane Eye Clinic
4
Link opens in a new tab
Citations
(Scopus)